Credit Suisse’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $502K | Buy |
|
|||||
|
2023
Q4 | $907K | Buy |
|
|||||
|
2023
Q3 | $637K | Sell |
|
|||||
|
2023
Q2 | $931K | Buy |
|
|||||
|
2023
Q1 | $764K | Buy |
|
|||||
|
2022
Q4 | $787K | Buy |
|
|||||
|
2022
Q3 | $689K | Buy |
|
|||||
|
2022
Q2 | $599K | Buy |
|
|||||
|
2022
Q1 | $663K | Buy |
|
|||||
|
2021
Q4 | $769K | Buy |
|
|||||
|
2021
Q3 | $784K | Buy |
|
|||||
|
2021
Q2 | $913K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $81K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $35K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $67K | Sell |
|
|||||
|
2018
Q4 | $57K | Sell |
|
|||||
|
2018
Q3 | $100K | Sell |
|
|||||
|
2018
Q2 | $98K | Sell |
|
|||||
|
2018
Q1 | $140K | Buy |
|
|||||
|
2017
Q4 | $153K | Sell |
|
|||||
|
2017
Q3 | $257K | Buy |
|
|||||
|
2017
Q2 | $231K | Buy |
|
|||||
|
2017
Q1 | $233K | Sell |
|
|||||
|
2016
Q4 | $194K | Sell |
|
|||||
|
2016
Q3 | $239K | Buy |
|
|||||
|
2016
Q2 | $314K | Sell |
|
|||||
|
2016
Q1 | $505K | Buy |
|
|||||
|
2015
Q4 | $543K | Buy |
|